Thomas Lipp

435 total citations
10 papers, 181 citations indexed

About

Thomas Lipp is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, Thomas Lipp has authored 10 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 5 papers in Hematology and 4 papers in Genetics. Recurrent topics in Thomas Lipp's work include Acute Lymphoblastic Leukemia research (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Thomas Lipp is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Thomas Lipp collaborates with scholars based in Germany. Thomas Lipp's co-authors include Dieter Hoelzer, Mathias Schmid, Nicola Goekbuget, Michael Kneba, Monika Brüggemann, Martin Mohren, Eckhard Thiel, Nadja Jaekel, Felix Kaul and Lothar Leimer and has published in prestigious journals such as Blood, Leukemia Research and Microorganisms.

In The Last Decade

Thomas Lipp

10 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Lipp Germany	7	140	92	54	46	42	10	181
M-C Béné France	5	146 1.0×	152 1.7×	23 0.4×	31 0.7×	40 1.0×	9	223
Joie Alvarez United States	2	136 1.0×	122 1.3×	64 1.2×	17 0.4×	26 0.6×	2	163
Maria Khouri United States	9	170 1.2×	102 1.1×	143 2.6×	56 1.2×	41 1.0×	22	233
Hester de Groot‐Kruseman Netherlands	4	240 1.7×	129 1.4×	58 1.1×	38 0.8×	157 3.7×	7	281
Phyllis Warkentin United States	6	104 0.7×	72 0.8×	81 1.5×	94 2.0×	32 0.8×	7	219
Nikola Hagedorn Germany	6	223 1.6×	158 1.7×	65 1.2×	30 0.7×	97 2.3×	11	258
Sabina Sufliarska Slovakia	6	57 0.4×	95 1.0×	32 0.6×	11 0.2×	24 0.6×	15	154
Montserrat Torrent Spain	5	43 0.3×	54 0.6×	23 0.4×	23 0.5×	20 0.5×	11	144
Y. Jabali Czechia	5	100 0.7×	83 0.9×	50 0.9×	27 0.6×	38 0.9×	10	228
Amado Karduss Colombia	5	57 0.4×	109 1.2×	32 0.6×	12 0.3×	17 0.4×	17	129

Countries citing papers authored by Thomas Lipp

Since Specialization

Citations

This map shows the geographic impact of Thomas Lipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lipp more than expected).

Fields of papers citing papers by Thomas Lipp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Lipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lipp. The network helps show where Thomas Lipp may publish in the future.

Co-authorship network of co-authors of Thomas Lipp

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Lipp. A scholar is included among the top collaborators of Thomas Lipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Lipp. Thomas Lipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Luo, Ji, Thomas Lipp, Julia Karbach, et al.. (2022). A Quantitative ELISA to Detect Anti-SARS-CoV-2 Spike IgG Antibodies in Infected Patients and Vaccinated Individuals. Microorganisms. 10(9). 1812–1812. 4 indexed citations

Hoelzer, Dieter, Felix Kaul, Nadja Jaekel, et al.. (2010). Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003. Blood. 116(21). 170–170. 67 indexed citations

Goekbuget, Nicola, Monika Brüggemann, Renate Arnold, et al.. (2009). New Definition of Treatment Response in Adult Acute Lymphoblastic Leukemia (ALL): Use of Molecular Markers for Minimal Residual Disease (MRD).. Blood. 114(22). 90–90. 9 indexed citations

Goekbuget, Nicola, Anja Baumann, Joachim Beck, et al.. (2008). PEG-Asparaginase in Adult Acute Lymphoblastic Leukemia (ALL): Efficacy and Feasibility Analysis with Increasing Dose Levels. Blood. 112(11). 302–302. 20 indexed citations

Gökbuget, Nicola, Renate Arnold, Angelika Böhme, et al.. (2007). Improved Outcome in High Risk and Very High Risk ALL by Risk Adapted SCT and in Standard Risk ALL by Intensive Chemotherapy in 713 Adult ALL Patients Treated According to the Prospective GMALL Study 07/2003.. Blood. 110(11). 12–12. 20 indexed citations

Sandholzer, Hagen, et al.. (2006). Der akute Bauchschmerz: zwischen banal und hochgefährlich. 32(5). 238–243. 1 indexed citations

Goekbuget, Nicola, Joachim Beck, H. Diedrich, et al.. (2005). Dexamethasone Dose and Schedule Significantly Influences Remission Rate and Toxicity of Induction Therapy in Adult Acute Lymphoblastic Leukemia (ALL): Results of the GMALL Pilot Trial 06/99.. Blood. 106(11). 1832–1832. 6 indexed citations

Goekbuget, Nicola, Eckhard Thiel, Joachim Beck, et al.. (2004). Improved Outcome in Adult T-ALL by Risk Adapted Treatment Strategies.. Blood. 104(11). 682–682. 6 indexed citations

Waßmann, Barbara, Roman Pfeifer, Urban Scheuring, et al.. (2003). Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib. Blood. 103(4). 1495–1498. 39 indexed citations

10.

Ho, Anthony D., Erhard Hiller, E. Thiel, et al.. (1990). Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma—Lack of a positive correlation between receptor levels and clinical responsiveness. Leukemia Research. 14(4). 327–332. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact